Therapeutic Plasma Exchange in Children - Experience From a Tertiary Care Center

Rufaida Mazahir1, Kanav Anand2, P K Pruthi2

  • 1Division of Pediatric Nephrology, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi. Correspondence to: Dr Rufaida Mazahir, Division of Pediatric Nephrology, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, Old Rajender Nagar, New Delhi 110 060. rufaidamazahir@gmail.com.

Indian Pediatrics
|June 29, 2021
PubMed

Insights

Therapeutic plasma exchange (TPE) is safe and effective in children for various conditions, including renal and neurological diseases. Most pediatric patients showed significant recovery with minimal complications during TPE procedures.

Area of Science:

  • Pediatric Nephrology
  • Pediatric Neurology
  • Apheresis Medicine

Background:

  • Therapeutic plasma exchange (TPE) is a critical extracorporeal treatment for various pediatric conditions.
  • Assessing TPE's safety and efficacy in pediatric populations is essential for guiding clinical practice.
  • Limited data exists on TPE outcomes specifically in children across diverse indications.

Purpose of the Study:

  • To evaluate the safety, efficacy, and clinical outcomes of therapeutic plasma exchange (TPE) in pediatric patients.
  • To identify common indications and patient demographics undergoing TPE in a pediatric setting.
  • To analyze the types and frequency of complications associated with TPE in children.

Main Methods:

  • Retrospective analysis of hospital records for pediatric patients (<=18 years) who underwent TPE.
  • Data collection spanned from August 2011 to July 2018.
  • TPE was performed using membrane plasma separation, with specific replacement fluids noted for different indications.

Main Results:

  • 46 children underwent 293 TPE sessions; renal diseases (52.2%) and neurological illnesses (36.9%) were primary indications.
  • Atypical hemolytic uremic syndrome (aHUS) was the most frequent diagnosis (34.8%).
  • 86.9% of patients achieved complete or partial recovery, with minor complications like blood pressure fluctuations occurring in 7.1% of sessions.

Conclusions:

  • Therapeutic plasma exchange (TPE) is a safe and effective treatment modality for pediatric patients with both renal and non-renal conditions.
  • TPE demonstrates positive outcomes even in younger children, supporting its use across a wide pediatric age range.
  • The study reinforces the utility of TPE in managing severe pediatric diseases, with a favorable safety profile.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
27
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
252
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
68
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
59
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
43